about Emmanuel Lacroix:
Emmanuel Lacroix is currently Senior Director Global Business Development at UCB, a global biopharmaceutical company, where he has responsibility for partnering and product licensing/acquisitions in Neurology (including with respect to rare neurological conditions). Previously in Sales & Global Marketing from 2007 to 2008, Emmanuel contributed to the coordination of global pre-launch activities for Vimpat® and the business planning for UCB’s other CNS products. Before joining UCB, from 2001 to 2005, Emmanuel was responsible for the engineering of Meganucleases at Cellectis SA, a French biotechnology start-up company where he last was Head of Department, leading multi-disciplinary teams that developed innovative, high-throughput drug discovery approaches. Emmanuel received an MBA from IMD (Switzerland) in 2006, a Ph.D. in Molecular Biology from the ULB (Belgium) based on protein engineering research conducted at the European Molecular Biology Laboratory (Germany), and a MSc in Biochemistry from the ULG (Belgium).